Related Experiment Video
Updated: Jul 17, 2026

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
Motohisa Yamamoto1, Hiroki Takahashi, Hideki Wakasugi
1First Department of Internal Medicine, Sapporo Medical University, School of Medicine, South 1-West 16, Sapporo 060-8543, Japan. mocha@cocoa.plala.or.jp
Abstract:
A 74-year-old Japanese woman was diagnosed with rheumatoid arthritis due to polyarthralgia. She was prescribed various disease-modifying anti-rheumatic drugs, but most of them were discontinued because of side effects or poor effectiveness. She was referred to our hospital in 2004, and etanercept was administered from June 2005. This resulted in rapid improvement of polyarthritis; however, she developed disorientation from February 2006. She was admitted to our hospital because of convulsions and loss of consciousness. She was diagnosed with progressive multifocal leukoencephalopathy on the basis of clinical symptoms and magnetic resonance imaging of the brain. In this significant and important case, leukoencephalopathy occurred during etanercept administration, and we refer to the risk of anti-TNFalpha drugs.
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
